Asahi Kasei Medical concluded an agreement on April 14, 2022 (JST) through a U.S. subsidiary to wholly acquire Bionova Scientific, LLC, a provider of contract process development services and GMP-compliant
In November 2021 Asahi Kasei, a diversified Japanese multinational company, conducted its third "Automotive Interior Survey" together with Cologne, Germany-based market research institute SKOPOS in the
Exclusive License with Asahi Kasei Pharma to develop and commercialize Apraglutide in Japan includes $30 million upfront cash payment, eligibility for up to $170 million in development and commercial. | March 30, 2022
Asahi Kasei Medical has decided to expand the production capacity of Planova filters by constructing a new assembly plant in Nobeoka, Miyazaki, Japan. The new plant will be designed to realize a smart